| abstract |
Methods for treating complement-mediated eye disorders, by administering agents that inhibit a component of the subject's complement in an amount sufficient to treat the eye disorder, wherein, in a selected modality, the agent is an anti-complement aptamer, which in a preferred modality , is an anti-C5 aptamer. |